|
| 35286809 | The Pandemic Response Boxâ¿¿Accelerating Drug Discovery Efforts after Disease Outbreaks. | ACS Infect Dis | 2022 |
| 35286809 | The Pandemic Response Boxâ¿¿Accelerating Drug Discovery Efforts after Disease Outbreaks. | ACS Infect Dis | 2022 |
| 31724231 | Facilities that make the PDB data collection more powerful. | Protein Sci | 2020 |
| 31724231 | Facilities that make the PDB data collection more powerful. | Protein Sci | 2020 |
| 31999695 | Reassessing therapeutic antibodies for neglected and tropical diseases. | PLoS Negl Trop Dis | 2020 |
| 31999695 | Reassessing therapeutic antibodies for neglected and tropical diseases. | PLoS Negl Trop Dis | 2020 |
| 28968694 | Bioinformatics in the Netherlands: the value of a nationwide community. | Brief Bioinform | 2019 |
| 28968694 | Bioinformatics in the Netherlands: the value of a nationwide community. | Brief Bioinform | 2019 |
| 31405382 | The bio.tools registry of software tools and data resources for the life sciences. | Genome Biol | 2019 |
| 31070161 | Partnering to fight malaria in India: Past, present and future. | J Vector Borne Dis | 2019 |
| 30902051 | Two successful decades of Swiss collaborations to develop new anti-malarials. | Malar J | 2019 |
| 30890711 | Addendum: The FAIR Guiding Principles for scientific data management and stewardship. | Sci Data | 2019 |
| 31405382 | The bio.tools registry of software tools and data resources for the life sciences. | Genome Biol | 2019 |
| 31070161 | Partnering to fight malaria in India: Past, present and future. | J Vector Borne Dis | 2019 |
| 30890711 | Addendum: The FAIR Guiding Principles for scientific data management and stewardship. | Sci Data | 2019 |
| 30902051 | Two successful decades of Swiss collaborations to develop new anti-malarials. | Malar J | 2019 |
| 29267862 | Bioinformatics in the Netherlands: the value of a nationwide community. | Brief Bioinform | 2018 |
| 30384848 | Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria. | Malar J | 2018 |
| 29909069 | Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. | Lancet Infect Dis | 2018 |
| 29860174 | The antimalarial pipeline. | Curr Opin Pharmacol | 2018 |
| 30526594 | A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria. | Malar J | 2018 |
| 29267862 | Bioinformatics in the Netherlands: the value of a nationwide community. | Brief Bioinform | 2018 |
| 29860174 | The antimalarial pipeline. | Curr Opin Pharmacol | 2018 |
| 29909069 | Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study. | Lancet Infect Dis | 2018 |
| 30526594 | A discovery and development roadmap for new endectocidal transmission-blocking agents in malaria. | Malar J | 2018 |
| 30384848 | Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria. | Malar J | 2018 |
| 28770814 | Malaria. | Nat Rev Dis Primers | 2017 |
| 28770814 | Malaria. | Nat Rev Dis Primers | 2017 |
| 28420400 | Erratum to: New developments in anti-malarial target candidate and product profiles. | Malar J | 2017 |
| 28751965 | Four simple recommendations to encourage best practices in research software. | F1000Res | 2017 |
| 28746372 | Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines. | PLoS Med | 2017 |
| 28086874 | New developments in anti-malarial target candidate and product profiles. | Malar J | 2017 |
| 28159843 | Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases. | J Biol Chem | 2017 |
| 28086874 | New developments in anti-malarial target candidate and product profiles. | Malar J | 2017 |
| 28159843 | Both Intrinsic Substrate Preference and Network Context Contribute to Substrate Selection of Classical Tyrosine Phosphatases. | J Biol Chem | 2017 |
| 28420400 | Erratum to: New developments in anti-malarial target candidate and product profiles. | Malar J | 2017 |
| 28751965 | Four simple recommendations to encourage best practices in research software. | F1000Res | 2017 |
| 28746372 | Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines. | PLoS Med | 2017 |
| 26978244 | The FAIR Guiding Principles for scientific data management and stewardship. | Sci Data | 2016 |
| 26978244 | The FAIR Guiding Principles for scientific data management and stewardship. | Sci Data | 2016 |
| 27044554 | Linking Murine and Human Plasmodium falciparum Challenge Models in a Translational Path for Antimalarial Drug Development. | Antimicrob Agents Chemother | 2016 |
| 27272721 | Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers. | J Antimicrob Chemother | 2016 |
| 27467575 | Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond. | PLoS Pathog | 2016 |
| 27516171 | Open data in drug discovery and development: lessons from malaria. | Nat Rev Drug Discov | 2016 |
| 27635232 | Top 10 metrics for life science software good practices. | F1000Res | 2016 |
| 27624471 | A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. | Malar J | 2016 |
| 27586084 | Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma. | Acta Neuropathol Commun | 2016 |
| 27586084 | Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma. | Acta Neuropathol Commun | 2016 |
| 27635232 | Top 10 metrics for life science software good practices. | F1000Res | 2016 |
| 27624471 | A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. | Malar J | 2016 |